Privacy statement »
Manage your email preferences »
Remember my details
DEEPGEN is a new option for pharmaceutical and biotech companies and their research partners for conducting liquidbiopsy-based research to investigate somatic mutational patterns specifically focused on the biomarker of cell-free DNA (cfDNA). DEEPGEN utilizes the most advanced sequencing technology to identify cfDNA and it utilizes proprietary software and pattern recognition technology to associate patterns with disease.